spec sheet10 rows
HXE, also called hydroxetamine, is an arylcyclohexylamine dissociative structurally related to ketamine and deschloroketamine. By analogy with other members of its class it is presumed to act principally as an antagonist of the NMDA subtype of glutamate receptor, producing dose-dependent detachment, sedation, and, at higher doses, an anesthetic-style dissociative state. It is an obscure research chemical with essentially no dedicated pharmacological or clinical literature; its presence has been documented mainly through forensic detection, including wastewater-based epidemiological monitoring of novel psychoactive substances. Consequently its true potency, metabolism, and safety margin remain poorly characterized relative to ketamine.
- Dose-dependent dissociation
- Analgesia (pain dulling)
- Euphoria and detachment
- NMDA receptor antagonist dissociative
- Ataxia (loss of coordination)
- Nausea and vomiting
- Confusion and memory gaps
- Possible bladder irritation with heavy use
Mechanism
HXE acts as a non-competitive at the (N-methyl-D-aspartate) receptor; it binds inside the open ion channel and blocks calcium and sodium flow, which dampens excitatory glutamate signaling and produces the dissociated, anesthetic-like state. As an arylcyclohexylamine it is presumed to share ketamine's channel-blocking site and likely has some affinity for other targets (such as sigma and monoamine transporters) reported for related compounds, though these are less well established for HXE specifically.
receptor fingerprint
Channel-blocking antagonist
Sigma-1 receptorPresumed agonist
Safetyrisks and cautions, not medical advice
Dissociatives blunt coordination and judgment, so falls, vomiting with a blocked airway, and dangerous decisions are real risks; heavy or frequent use invites strong psychological compulsion and, with some arylcyclohexylamines, urinary/bladder problems. Mixing with other depressants (alcohol, benzodiazepines, opioids, GHB) stacks sedation and can suppress breathing. Because HXE's potency is poorly mapped, the gap between a light and a very heavy experience can be smaller than expected. Not medical advice.
Subjective profileweighing the evidence above
Almost nothing is known about this one, including how far apart a light dose and a very heavy one really are. Ketamine and even deschloroketamine are better mapped, which makes HXE hard to justify to anyone.
Resources
This entry is here for reference.
Research
- 2022first citedArylcyclohexylamine Derivatives: Pharmacokinetic, Pharmacodynamic, Clinical and Forensic Aspects
- 2026most recentEmerging new psychoactive ketamine analogues: patterns of use and health risks identified by th…
- 1.Arylcyclohexylamine Derivatives: Pharmacokinetic, Pharmacodynamic, Clinical and Forensic Aspects
- 2.Emerging new psychoactive ketamine analogues: patterns of use and health risks identified by the French Addictovigilance Network
- 3.Monitoring the use of novel psychoactive substances in Australia by wastewater-based epidemiology.
3 listed here; entry last updated July 2026
Reviews
My notesprivate to this device
FAQ
Is HXE the same as ketamine?
No. It is a chemical cousin in the same arylcyclohexylamine family and shares the NMDA-blocking mechanism, but it is a distinct research chemical with much less safety data.
Why is the dosing so uncertain?
There is very little published human pharmacology for HXE, so its potency relative to ketamine is not reliably established, which makes it easy to misjudge.
Can it cause bladder problems?
Some arylcyclohexylamines are linked to painful bladder damage with heavy repeated use, so it is a plausible risk here too.
Adverse effects
- Ataxia (loss of coordination)
- Nausea and vomiting
- Confusion and memory gaps
- Possible bladder irritation with heavy use